Brian M. Necela

机构：Nemours Children’s Clinic, Mayo Clinic in Florida · ORCID：0000-0002-4409-1245

发表论文 122 篇 · 总被引 3096 次 · h-index 26

代表论文

• Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade (2023 · Journal for ImmunoTherapy of Cancer · 被引 25)
• Comprehensive profiling of cancer neoantigens from aberrant RNA splicing (2024 · Journal for ImmunoTherapy of Cancer · 被引 11)
• A phase I pilot study of personalized neoantigen peptide-based vaccine in combination with pembrolizumab in advanced solid tumors (PNeoVCA). (2024 · Journal of Clinical Oncology · 被引 6)
• BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression (2024 · Frontiers in Endocrinology · 被引 4)
• Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti–Tumor Necrosis Factor Therapy (2024 · Clinical and Translational Gastroenterology · 被引 4)
• Abstract P3-10-16: Phase I/II of Personalized Neoantigen Peptide-Based Vaccine (PNeoVCA) in Combination with Pembrolizumab in Patients with Early-Stage Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy (2025 · Clinical Cancer Research · 被引 1)